Atlas Trials

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

Clinical trial NCT06033703 · RECRUITING

Trial details

NCT number
NCT06033703
Sponsor
Massachusetts Eye and Ear Infirmary
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Start date
2025-01-14
Primary completion
2026-09-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.